Page last updated: 2024-11-04

saccharin and Parkinsonian Disorders

saccharin has been researched along with Parkinsonian Disorders in 2 studies

Saccharin: Flavoring agent and non-nutritive sweetener.
saccharin : A 1,2-benzisothiazole having a keto-group at the 3-position and two oxo substituents at the 1-position. It is used as an artificial sweetening agent.

Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Quik, M1
Campos, C1
Grady, SR1
Paumier, KL1
Sortwell, CE1
Madhavan, L1
Terpstra, B1
Celano, SL1
Green, JJ1
Imus, NM1
Marckini, N1
Daley, B1
Steece-Collier, K1
Collier, TJ1

Other Studies

2 other studies available for saccharin and Parkinsonian Disorders

ArticleYear
Multiple CNS nicotinic receptors mediate L-dopa-induced dyskinesias: studies with parkinsonian nicotinic receptor knockout mice.
    Biochemical pharmacology, 2013, Oct-15, Volume: 86, Issue:8

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Central Nervous System; Cotinine; Dopamine; Dyskin

2013
Chronic amitriptyline treatment attenuates nigrostriatal degeneration and significantly alters trophic support in a rat model of parkinsonism.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015, Volume: 40, Issue:4

    Topics: Adrenergic Agents; Amitriptyline; Analgesics, Non-Narcotic; Animals; Brain-Derived Neurotrophic Fact

2015